Name
Prevention & Control (antivirals): Oral Abstract Presentations
Date & Time
Thursday, September 11, 2025, 9:00 AM - 10:00 AM
Description
Session Chairs:
Kim Green
Jason MacKenzie
Oral Abstracts:
- VIRTUAL PRESENTATION: Development of Reporter Replicon Systems for Genogroup II Human Noroviruses: Tools for Antiviral Screening and Mechanistic Insight & Evaluation of MMV Pandemic Response Box compounds identifies MMP-inhibitor against HuNoV replication
- Myra Hosmillo, University of Cambridge
- Oral Direct-Acting Antiviral CDI-988 for norovirus infection prevention and treatment: Mechanism of Action and Phase 1 Study Results
- Sam Lee, Cocrystal Pharma Inc.
- Polyamine depletion inhibits norovirus infection and blocks virus-induced apoptosis
- Stefan Taube, University of Lübeck
- Targeting calicivirus entry – a VP2 peptide inhibitor of Feline Calicivirus
- Charlotte Lewis, University of Glasgow Centre for Virus Research
Location Name
Kinnear Centre 101/103/105
Full Address
Banff Centre for Arts + Creativity
107 Tunnel Mountain Dr.
Banff AB T1L 1H5
Canada
107 Tunnel Mountain Dr.
Banff AB T1L 1H5
Canada